Best Kinase Inhibitor for idiopathic pulmonary fibrosis
The 2 Kinase Inhibitor options we list for idiopathic pulmonary fibrosis are all Nintedanib Esylate— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for idiopathic pulmonary fibrosis or the full Kinase Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 kinase inhibitor drugs we rate for idiopathic pulmonary fibrosis, none are yet flagged as generics in our price data, and most are capsule. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for idiopathic pulmonary fibrosis; the right choice depends on your situation, so confirm it with your prescriber.
How kinase inhibitor work
Kinase inhibitors block protein kinases, the enzymes that relay 'grow and divide' signals inside cells. By shutting down the overactive kinase signals that a tumor depends on, they help slow or stop cancer cells from multiplying.
Source: Tyrosine Kinase Inhibitors - StatPearls - NCBI Bookshelf
These are all Nintedanib Esylatein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 kinase inhibitor products
ofev
PrescriptionFDA-sourced
Ofev (Nintedanib Esylate) is a kinase inhibitor used to treat Idiopathic Pulmonary Fibrosis.
Price varies
nintedanib esylate
PrescriptionFDA-sourced
Nintedanib Esylate is a kinase inhibitor used to treat Idiopathic Pulmonary Fibrosis.
Price varies
Frequently asked
- What is the best kinase inhibitor for idiopathic pulmonary fibrosis?
- The Kinase Inhibitor options we list for idiopathic pulmonary fibrosis are all Nintedanib Esylate — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which kinase inhibitor drugs treat idiopathic pulmonary fibrosis?
- pharmaranks lists 2 Kinase Inhibitor products used for idiopathic pulmonary fibrosis, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.